Contamination of the skin and clothing of healthcare workers happened frequently during the removal of gloves or gowns in a simulation study published by JAMA Internal Medicine that used fluorescent lotion and black light. The study by Curtis J. Donskey, MD, of the Cleveland Veterans Affairs Medical Center, and coauthors included healthcare workers at four northeast Ohio hospitals who participated in personal protective equipment (PPE) removal simulations. Other healthcare personnel at one medical center participated in an intervention that included education and practice in removal of contaminated PPE.
The authors report that of 435 glove and gown removal simulations, contamination of skin or clothing with fluorescent lotion happened in 200 (46 percent). The intervention reduced skin and clothing contamination during glove and gown removal (60 percent before the intervention vs. 18.9 percent after) that was sustained after one and three months.
“These findings highlight the urgent need for additional studies to determine effective strategies to minimize the risk of contamination during PPE removal, to improve PPE design and to identify optimal methods for training of personnel in PPE use,” the authors write.
Reference: JAMA Intern Med. Published online Oct. 12, 2015. doi:10.1001/jamainternmed.2015.4535.
Editor’s Note: An author made a conflict of interest disclosure. This work was supported by a Veterans Affairs Merit Review grant from the Department of Veterans Affairs, the Cleveland Veterans Affairs Geriatric Research, Education and Clinical Center and a grant from STERIS.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.